48,474
edits
Difference between revisions of "Apocrine carcinoma of the breast"
Jump to navigation
Jump to search
Apocrine carcinoma of the breast (view source)
Revision as of 01:17, 10 February 2016
, 01:17, 10 February 2016→IHC
(→IHC) |
|||
| Line 63: | Line 63: | ||
==IHC== | ==IHC== | ||
Smaller tumours classically:<ref name=pmid16045781>{{Cite journal | last1 = Honma | first1 = N. | last2 = Takubo | first2 = K. | last3 = Akiyama | first3 = F. | last4 = Sawabe | first4 = M. | last5 = Arai | first5 = T. | last6 = Younes | first6 = M. | last7 = Kasumi | first7 = F. | last8 = Sakamoto | first8 = G. | title = Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. | journal = Histopathology | volume = 47 | issue = 2 | pages = 195-201 | month = Aug | year = 2005 | doi = 10.1111/j.1365-2559.2005.02181.x | PMID = 16045781 }}</ref> | Smaller tumours classically:<ref name=pmid16045781>{{Cite journal | last1 = Honma | first1 = N. | last2 = Takubo | first2 = K. | last3 = Akiyama | first3 = F. | last4 = Sawabe | first4 = M. | last5 = Arai | first5 = T. | last6 = Younes | first6 = M. | last7 = Kasumi | first7 = F. | last8 = Sakamoto | first8 = G. | title = Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. | journal = Histopathology | volume = 47 | issue = 2 | pages = 195-201 | month = Aug | year = 2005 | doi = 10.1111/j.1365-2559.2005.02181.x | PMID = 16045781 }}</ref> | ||
*AR +ve. | *[[Androgen receptor|AR]] +ve. | ||
*[[GCDFP-15]] +ve. | *[[GCDFP-15]] +ve. | ||
Usually:<ref name=Ref_BP217>{{Ref BP|217}}</ref> | Usually:<ref name=Ref_BP217>{{Ref BP|217}}</ref> | ||